Cellectis Reports Financial Results for First Quarter 2024
• Cellectis announced completion of the additional equity investment of $140M by AstraZeneca
Source: eagletribune.com
📰 Regarding Use News
Regarding Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Regarding Use. Real-time updates on events, politics, business and more.
C3 AI Announces Fiscal Fourth Quarter and Full Fiscal Year 2024 Financial Results
Increasing Revenue Growth. Raising Guidance. Growth Accelerates for Fifth Consecutive Quarter, Record Federal Growth Subscription Revenue for the Fourth Quarter Increased 41% Year-Over-Year ...
Wright Patterson Air Force Base United States Riverside County Jim Fitterling Tom Magee Jimmy Lawrence
Source: marketscreener.com
Cellectis Reports Financial Results For First Quarter 2024
. Cellectis announced completion of the additional equity investment of $140M by AstraZeneca . Cash position of $143 million as of March 31
United States United Kingdom Marc Dunoyer Bing Wang International Accounting Standards Board Cellectis The Company Euronext Growth
Source: menafn.com
Hall of Fame Resort & Entertainment : First Quarter Earnings Presentation
First Quarter Fiscal 2024 Earnings Supplementary Information May 2024 Who We Are W H A T W...
Source: marketscreener.com
Snowflake Reports Financial Results for the First Quarter of Fiscal 2025
22.05.2024 - Snowflake (NYSE: SNOW), the AI Data Cloud company, today announced financial results for its first quarter of fiscal 2025, ended April 30, 2024. This press release features multimedia. View the full release here: ...
Source: wallstreet-online.de
Glaukos Announces First Quarter 2024 Financial Results
Glaukos Corporation , an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced...
Thomas Burns Corneal Health Exchange Commission Glaukos Corporation International Glaucoma Avedro Inc
Source: marketscreener.com
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
• Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology 65th Annual Meeting • Execution of strategic...
Source: marketscreener.com
B. Riley Financial Files 2023 Annual Report on Form 10-K
/PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("B. Riley" or the "Company"), a diversified financial services platform, today announced the filing of...
Bryant Riley Mike Frank Brian Kahn Jo Anne Mccusker Sullivan Cromwell Audit Committee Independent Legal Counsel
Source: prnewswire.com
Avid Bioservices Reports Financial Results for Third
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- --...
Nick Green Exchange Commission Avid Bioservices Inc Completion Of Recent Expansion Program Third Quarter Revenue Net New Business Resulting
Source: globenewswire.com
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...
Nick Green Globenewswire Inc Exchange Commission Completion Of Recent Expansion Program Avid Bioservices Inc Third Quarter Revenue
Source: marketscreener.com